Source: Investing.com ↗

Neurocrine in the spotlight as Q2 earnings test growth story

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

BTC/USDT

$63,049.09

-2.61%

ETH/USDT

$1,864.55

-2.89%

USDC/USDT

$1.00

+0.02%

HPET/USDT

$0.00002035

+36.03%

9bit/USDT

$0.0496

+3.05%